Jorgensen Nathan D. 4
4 · Vor Biopharma Inc. · Filed May 7, 2024
Insider Transaction Report
Form 4
Jorgensen Nathan D.
Chief Financial Officer
Transactions
- Tax Payment
Common Stock
2024-05-06$1.75/sh−834$1,460→ 189,403 total
Footnotes (1)
- [F1]Shares were withheld to satisfy the Reporting Person's tax withholding obligations in connection with the settlement of restricted stock units.